Altered cell differentiation and proliferation in mice lacking p57(KIP2) indicates a role in Beckwith-Wiedemann syndrome

Nature

Volumn 387, Issue 6629, 1997, Pages 151-158

  Zhang, Pumin ^a   Liégeois, Nanette J ^b   Wong, Calvin ^a   Finegold, Milton ^a   Hou, Harry ^b   Thompson, Janet C ^a   Silverman, Adam ^b   Harper, J Wade ^a   DePinho, Ronald A ^b   Elledge, Stephen J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR;

ABDOMINAL WALL MUSCULATURE; ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BECKWITH WIEDEMANN SYNDROME; CANCER SUSCEPTIBILITY; CELL DIFFERENTIATION; CELL PROLIFERATION; CHROMOSOME 11P; CLEFT PALATE; CUSHING SYNDROME; EMBRYO; ENCHONDRAL OSSIFICATION; KIDNEY DYSPLASIA; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ABDOMEN; ABNORMALITIES, MULTIPLE; ADRENAL CORTEX; ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; BECKWITH-WIEDEMANN SYNDROME; CARTILAGE; CELL DIFFERENTIATION; CELL DIVISION; CROSSES, GENETIC; CYCLIN-DEPENDENT KINASE INHIBITOR P57; CYCLIN-DEPENDENT KINASES; ENZYME INHIBITORS; FEMALE; GENE EXPRESSION; GENE TARGETING; HERNIA, UMBILICAL; KIDNEY MEDULLA; LENS, CRYSTALLINE; MALE; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; NUCLEAR PROTEINS; OSTEOGENESIS;

EID: 1842335753     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/387151a0     Document Type: Article

References (33)

1. Harper, J. W. & Elledge, S. J. Cdk inhibitors in development and cancer. Curr. Opin. Genet. Dev. 6, 56-64 (1996).
2. Sherr, C. J. Cancer cell cycles. Science 274, 1672-1677 (1996).
3. Weinberg, R. A. The retinoblastoma protein and cell cycle control. Cell 81, 323-330 (1995).
4. Serrano M. et al. Role of the INK4a locus in tumor suppression and cell mortality. Cell 85, 27-37 (1996).
5. Cip1 in muscle and other terminally differentiating cells. Science 267, 1024-1027 (1995).
6. CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82, 675-684 (1995).
7. KIP1 display increased body size, multiple organ hyperplasia, retinal displasia, and pituitary tumors. Cell 85, 707-720 (1996).
8. KIP1. Cell 85, 721-732 (1996).
9. Kip1-deficient mice. Cell 85, 733-744 (1996).
10. CIP1 Cdk-inhibitor family, is a candidate tumor suppressor gene. Genes Dev. 9, 650-662 (1995).
11. KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev. 9, 639-649 (1995).
12. Hastie, N. D. The genetics of Wilms' tumor - a case of disrupted development. Annu. Rev. Genet. 28, 523-558 (1994).
13. Wiedemann, H. R. Tumours and hemihypertrophy associated with Wiedemann-Beckwith sydrome. Eur. J. Pediatr. 141, 129-134 (1983).
14. Junien, C. Beckwith-Wiedemann syndrome, tumourigenesis and imprinting. Curr. Opin. Biol. 2, 431-438 (1992).
15. KIP2, on chromosome 11p15. Proc. Natl Acad. Sci. USA 93, 3026-3030 (1996).
16. KIP2, a cyclin-dependent kinase inhibitor, in mouse, Nature Genet. 11, 204-206 (1995).
17. Hoovers, J. et al. Multiple genetic loci within 11p15.5 defined by Beckwith-Wiedemann Sydrome rearrangement breakpoints and subchromosomal transferable fragments. Proc. Natl Acad. Sci. USA 92, 12456-12460 (1995).
18. KIP2 is mutated in Beckwith-Wiedemann syndrome. Nature Genet. 14, 171-173 (1996).
19. Kaufman, M. H. The Atlas of Mouse Development (Academic, London, 1992).
20. Ferguson, M. J. W. Palate development. Development (suppl.) 103, 41-60 (1988).
21. Beckwith, B. Macroglossia, omphalocele, adrenal cytomegaly, gigantism, and hyperplastic visceromegaly. Birth Defects: Original Article Series 2 Vol. V No. 2 (ed. Bergsma, D.) 188-196 (The National Foundation, 1969).
22. Hepinstall, R. H. in Pathology of the Kidney Vol. 1, 114-155 (Little, Brown, Boston, MA, 1992).
23. Jacenko, O. et al. Spondylometaphyseal dysplasia in mice carrying a dominant negative mutation in a matrix protein specific for cartilage-to-bone transition. Nature 365, 56-61 (1993).
24. McAvoy, J. W. Induction of the eye lens. Differentiation 17, 137-149 (1996).
25. Morgenbesser, S. D. et al. p53-dependent apoptosis produced by Rb deficiency in the developing mouse lens. Nature 371, 72-74 (1994).
26. Cobrink, D. et al. Shared role of the Rb-related p130 and p107 proteins in limb development. Genes Dev. 10, 1633-1644 (1996).
27. Elliott, M. et al. Clinical features and natural history of Beckwith-Wiedemann syndrome: presentation of 74 new cases. Clin. Genet. 46, 168-174 (1994).
28. Takato, T., Kamei, M., Kato, K. & Kitano, I. Cleft palate in the Beckwith-Wiedemann syndrome. Ann. Plastic Surg. 22, 347-349 (1989).
29. Sotelo-Avila, C., Gonzalez-Crussi, F. & Fowler, J. W. Complete and incomplete forms of Beckwith-Wiedemann syndrome: their oncogenic potential J. Pediatr. 96, 47-50 (1980).
30. Leighton, P. A. et al. Disruption of imprinting caused by deletion of the H19 gene region in mice. Nature 375, 34-39 (1995).
31. Weksberg, R., Shem, D. R., Song, Q. L. & Squire, J. Disruption of IGF2 imprinting in Beckwith-Wiedemann Syndrome. Nature Genet. 5, 143-149 (1993).
32. Ramírez-Solis, R. et al. Hoxb-4 (Hox-2.6) mutant mice show homeotic transformation of a cervical vertebra and defects in the closure of the sternal rudiments. Cell 73, 279-294 (1993).
33. Dynlacht, B. D. et al. Purification and analysis of CIP/KIP proteins. Methods Enzymol. (in the press).